Christopher R. Fenimore - 16 Dec 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Finance & CFO
Signature
/s/ Christopher R. Fenimore
Issuer symbol
REGN
Transactions as of
16 Dec 2024
Net transactions value
-$358,828
Form type
4
Filing time
18 Dec 2024, 16:01:20 UTC
Previous filing
10 Dec 2024
Next filing
09 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability $358,828 -491 -2.9% $730.81 16,265 16 Dec 2024 Direct
holding REGN Common Stock 1,515 16 Dec 2024 By 401(k) Plan
holding REGN Common Stock 1,897 16 Dec 2024 By Trust F1
holding REGN Common Stock 25 16 Dec 2024 by Trust for Daugh
holding REGN Common Stock 25 16 Dec 2024 by Trust for Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.